Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 13;8(3):32.
doi: 10.3390/medsci8030032.

Antimicrobial Susceptibilities and Laboratory Profiles of Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis Isolates as Agents of Urinary Tract Infection in Lebanon: Paving the Way for Better Diagnostics

Affiliations

Antimicrobial Susceptibilities and Laboratory Profiles of Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis Isolates as Agents of Urinary Tract Infection in Lebanon: Paving the Way for Better Diagnostics

Elie S Sokhn et al. Med Sci (Basel). .

Abstract

Background: Urinary tract infections (UTIs) are major healthcare problems that are usually treated empirically. However, antimicrobial resistance has been increasing across many settings. This study aims to elucidate the antibiotic resistance profiles of three common uropathogens, Escherichia coli (E. coli), Klebsiella pneumoniae (K. pneumoniae), and Proteus mirabilis (P. mirabilis) and compare between extended spectrum beta-lactamase (ESBL) and non-ESBL strains among Lebanese patients. Methods: This retrospective study was conducted at multiple tertiary healthcare centers in South Lebanon, between January and September 2017, including 551 patients of all age groups. Demographic, clinical, and laboratory data of patients were collected and analyzed statistically. Results: The prevalence of UTI in Lebanon was highest in adults between 19 and 64 years (44%). E. coli was the predominant uropathogenic organism (67.1%) followed by K. pneumoniae (10%) and P. mirabilis (3.7%). ESBL represented 32.9% of the UTI agents. The three common uropathogens studied were found to be most susceptible to imipenem (100%) and meropenem (100%). Interestingly, 115 (25.1%) out of the 458 E. coli isolates were resistant to more than eight antibiotics while 107 (23.4%) were susceptible to all antibiotics studied. Conclusions: Our study underlined the importance of adequate antimicrobial prescription for UTIs in Lebanon to avoid multidrug resistance.

Keywords: ESBL; Escherichia coli; Lebanon; antimicrobial susceptibilities; urinary tract infections.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Monthly distribution of different uropathogens from January to September 2017 in UTI patients. E. coli (in red), K. pneumoniae (in blue), and P. mirabilis (in black).

Similar articles

Cited by

References

    1. Alanazi M.Q., Alqahtani F.Y., Aleanizy F.S. An evaluation of E. coli in urinary tract infection in emergency department at KAMC in Riyadh, Saudi Arabia: Retrospective study. Ann. Clin. Microbiol. Antimicrob. 2018;17:3. doi: 10.1186/s12941-018-0255-z. - DOI - PMC - PubMed
    1. Hyun M., Lee J.Y., Kim H.A., Ryu S.Y. Comparison of Escherichia coli and Klebsiella pneumoniae Acute Pyelonephritis in Korean Patients. Infect. Chemother. 2019;51:130–141. doi: 10.3947/ic.2019.51.2.130. - DOI - PMC - PubMed
    1. Al-Badr A., Al-Shaikh G. Recurrent Urinary Tract Infections Management in Women: A review. Sultan Qaboos Univ. Med. J. 2013;13:359–367. doi: 10.12816/0003256. - DOI - PMC - PubMed
    1. Foxman B. The epidemiology of urinary tract infection. Nat. Rev. Urol. 2010;7:653–660. doi: 10.1038/nrurol.2010.190. - DOI - PubMed
    1. Rubin R.H., Shapiro E.D., Andriole V.T., Davis R.J., Stamm W.E. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin. Infect. Dis. An Off. Publ. Infect. Dis. Soc. Am. 1992;15(Suppl. 1):S216–S227. doi: 10.1093/clind/15.Supplement_1.S216. - DOI - PubMed

LinkOut - more resources